Top compounds associated with response to TLCD2


Feature Type Standardized
Nominal ANOVA
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.035 0.4
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.044 0.4
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.4
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.4
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.038 0.4
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.035 0.4
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.048 0.4
mRNA tigecycline CTRPv2 pan-cancer AAC -0.049 0.4
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.036 0.4
mRNA ML258 CTRPv2 pan-cancer AAC 0.037 0.4
Download CSV